Fructose-1,6-diphosphate inhibits viral replication
Author Information
Author(s): Hu Penghui, Li Huiyi, Ji Zemin, Jing Weijia, Li Zihan, Yu Sujun, Shan Xiao, Cui Yan, Wang Baochen, Dong Hongyuan, Zhou Yanzhao, Wang Zhe, Xiong Hui, Zhang Xiaomei, Li Hui-chieh, Wang Jinrong, Tang Jiuzhou, Wang Ting, Xie Keliang, Liu Yuping, Zhu Haizhen, Yu Qiujing
Primary Institution: Tianjin Medical University General Hospital, Tianjin, China
Hypothesis
The study investigates the role of fructose-1,6-diphosphate (FBP) in inhibiting viral infections.
Conclusion
FBP can inhibit viral replication by promoting the lysosomal degradation of HMGB1 and preventing its binding to viral genomes.
Supporting Evidence
- FBP levels increase in virus-infected cells.
- Exogenous FBP inhibits both RNA and DNA virus infections in vitro and in vivo.
- FBP reduces HMGB1 protein levels by promoting its lysosomal degradation.
- FBP interacts with HMGB1 and blocks its binding to viral genomes.
- FBP treatment leads to lower mortality rates in mice infected with VSV.
Takeaway
Fructose-1,6-diphosphate helps stop viruses from making copies of themselves by breaking down a protein that viruses need to grow.
Methodology
The study used in vitro and in vivo experiments to assess the effects of FBP on viral infections, measuring RNA levels and viral titers.
Limitations
The study does not explore the long-term effects of FBP treatment on viral infections.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website